Education
About Us
Working with TipRanks
Follow Us
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 43.00K | $ 420.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 37.00K | $ 420.00K | $ -32.00K | $ -43.00K | $ -20.00K |
| Operating Income | $ -12.00M | $ -25.45M | $ -27.66M | $ -22.94M | $ -10.64M |
| EBITDA | $ -12.00M | $ -25.42M | $ -27.62M | $ -22.69M | $ -10.62M |
| Net Income | $ -11.21M | $ -22.55M | $ -21.20M | $ -18.89M | $ -8.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.14M | $ 3.38M | $ 18.34M | $ 36.56M | $ 33.41M |
| Total Assets | $ 4.09M | $ 8.80M | $ 27.50M | $ 42.59M | $ 36.80M |
| Total Debt | $ 0.00 | $ 37.00K | $ 106.00K | $ 30.00K | $ 1.06M |
| Net Debt | $ -3.14M | $ -3.34M | $ -18.24M | $ -36.53M | $ -32.35M |
| Total Liabilities | $ 6.27M | $ 8.20M | $ 11.99M | $ 5.32M | $ 3.54M |
| Stockholders' Equity | $ -2.17M | $ 607.00K | $ 15.51M | $ 37.26M | $ 33.26M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.99M | $ -16.12M | $ -20.83M | $ -18.57M | $ -8.03M |
| Operating Cash Flow | $ -7.99M | $ -16.11M | $ -20.83M | $ -18.54M | $ -7.93M |
| Investing Cash Flow | $ 0.00 | $ -6.00K | $ -7.00K | $ -27.00K | $ -96.00K |
| Financing Cash Flow | $ 7.82M | $ 848.00K | $ 3.00M | $ 21.74M | $ 29.50M |
Cyclacel Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.